Projects

Selected programs and ecosystem initiatives

BioVergence supports both third-party scientific assets and selectively originated programs across therapeutics, diagnostics, peptides, modular science infrastructure, and adjacent platform opportunities.

  • Ventures at the edge of science.

Initiatives

Current and emerging initiatives

Our projects span platform infrastructure, product/protocol programs, diagnostics, immunology, and modular science ventures designed to fit BioV's broader capital-formation thesis.

Projects in development

Regenerative Medicine

SmartWeave

Overview

Personalized, AI-driven platform for surgical implants, combining biomaterials, virtual human twins, and 3D bioprinting.

Learn More

Regenerative Medicine

SmartWeave

Overview

Personalized, AI-driven platform for surgical implants, combining biomaterials, virtual human twins, and 3D bioprinting.

Learn More

Regenerative Medicine

SmartWeave

Overview

Personalized, AI-driven platform for surgical implants, combining biomaterials, virtual human twins, and 3D bioprinting.

Learn More

Regenerative Immunology

ImmuneInk

Overview

Immune-modulated regenerative tissues for cardiac, autoimmune, and oncology use cases.

Learn More

Regenerative Immunology

ImmuneInk

Overview

Immune-modulated regenerative tissues for cardiac, autoimmune, and oncology use cases.

Learn More

Regenerative Immunology

ImmuneInk

Overview

Immune-modulated regenerative tissues for cardiac, autoimmune, and oncology use cases.

Learn More

Synthetic Diagnostics

PathCrisp

Overview

PathCrisp is a next-gen diagnostics platform combining CRISPR-based detection, microfluidic hardware, and cloud-based bioinformatics. Focused on identifying multi-pathogen threats and antimicrobial resistance, this project is built for high-impact deployment in both clinical and field settings.

Learn More

Synthetic Diagnostics

PathCrisp

Overview

PathCrisp is a next-gen diagnostics platform combining CRISPR-based detection, microfluidic hardware, and cloud-based bioinformatics. Focused on identifying multi-pathogen threats and antimicrobial resistance, this project is built for high-impact deployment in both clinical and field settings.

Learn More

Synthetic Diagnostics

PathCrisp

Overview

PathCrisp is a next-gen diagnostics platform combining CRISPR-based detection, microfluidic hardware, and cloud-based bioinformatics. Focused on identifying multi-pathogen threats and antimicrobial resistance, this project is built for high-impact deployment in both clinical and field settings.

Learn More

MRNA Vaccines

Srishti Therapeutics

Overview

Srishti Therapeutics is developing mRNA vaccines targeting vector-borne diseases using hybrid antigen design. Supported by philanthropic grants, the project is advancing toward IND readiness and exploring new financial mechanisms to scale impact across underserved regions.

Learn More

MRNA Vaccines

Srishti Therapeutics

Overview

Srishti Therapeutics is developing mRNA vaccines targeting vector-borne diseases using hybrid antigen design. Supported by philanthropic grants, the project is advancing toward IND readiness and exploring new financial mechanisms to scale impact across underserved regions.

Learn More

MRNA Vaccines

Srishti Therapeutics

Overview

Srishti Therapeutics is developing mRNA vaccines targeting vector-borne diseases using hybrid antigen design. Supported by philanthropic grants, the project is advancing toward IND readiness and exploring new financial mechanisms to scale impact across underserved regions.

Learn More

Integrated Therapeutics

CureGen

Overview

CureGen fuses gene editing, advanced biofabrication, and AI-powered analytics to accelerate disease understanding and therapeutic development.

Learn More

Integrated Therapeutics

CureGen

Overview

CureGen fuses gene editing, advanced biofabrication, and AI-powered analytics to accelerate disease understanding and therapeutic development.

Learn More

Integrated Therapeutics

CureGen

Overview

CureGen fuses gene editing, advanced biofabrication, and AI-powered analytics to accelerate disease understanding and therapeutic development.

Learn More

Climate Risk Modeling

Climactic

Overview

Climactic provides AI-based predictive models for climate risk mitigation, supporting adaptation, insurance, and resilience solutions.

Learn More

Climate Risk Modeling

Climactic

Overview

Climactic provides AI-based predictive models for climate risk mitigation, supporting adaptation, insurance, and resilience solutions.

Learn More

Climate Risk Modeling

Climactic

Overview

Climactic provides AI-based predictive models for climate risk mitigation, supporting adaptation, insurance, and resilience solutions.

Learn More

Applications

Verticals we are innovating

Verticals we are innovating

Smart Farming

Personalized Medicine

Wearable Health Devices

Personalized Medicine

3D Bio Printing

Personalized Medicine

Genetically Modified Organisms

Personalized Medicine

Bioremediation

Personalized Medicine

Bio Fuels

Personalized Medicine

Personalized Medicine

Bio-Pharmaceuticals

Biopharmaceuticals

Personalized Medicine

Regenerative Medicine

Personalized Medicine

FAQ

Frequently asked questions

Frequently asked questions

Frequently asked questions

What is your tokenization process?
Where do the scientific assets come from?
Who is BioVergence for?
How do I get started?

Modular bioscience, at your fingertips

Modular bioscience, at your fingertips

Modular bioscience, at your fingertips

AI-native capital formation for scientific assets

Address

750 Main Street, Cambridge, MA 02139, USA

Poststrasse 30, 6300 Zug, Switzerland

©2026 BioVergence All Rights Reserved

AI-native capital formation for scientific assets

Address

750 Main Street, Cambridge, MA 02139, USA

Poststrasse 30, 6300 Zug, Switzerland

©2026 BioVergence All Rights Reserved

Projects

Selected programs and ecosystem initiatives

BioVergence supports both third-party scientific assets and selectively originated programs across therapeutics, diagnostics, peptides, modular science infrastructure, and adjacent platform opportunities.

  • Ventures at the edge of science.

Initiatives

Current and emerging initiatives

Our projects span platform infrastructure, product/protocol programs, diagnostics, immunology, and modular science ventures designed to fit BioV's broader capital-formation thesis.

Projects in development

Regenerative Medicine

SmartWeave

Overview

Personalized, AI-driven platform for surgical implants, combining biomaterials, virtual human twins, and 3D bioprinting.

Learn More

Regenerative Medicine

SmartWeave

Overview

Personalized, AI-driven platform for surgical implants, combining biomaterials, virtual human twins, and 3D bioprinting.

Learn More

Regenerative Medicine

SmartWeave

Overview

Personalized, AI-driven platform for surgical implants, combining biomaterials, virtual human twins, and 3D bioprinting.

Learn More

Regenerative Immunology

ImmuneInk

Overview

Immune-modulated regenerative tissues for cardiac, autoimmune, and oncology use cases.

Learn More

Regenerative Immunology

ImmuneInk

Overview

Immune-modulated regenerative tissues for cardiac, autoimmune, and oncology use cases.

Learn More

Regenerative Immunology

ImmuneInk

Overview

Immune-modulated regenerative tissues for cardiac, autoimmune, and oncology use cases.

Learn More

Synthetic Diagnostics

PathCrisp

Overview

PathCrisp is a next-gen diagnostics platform combining CRISPR-based detection, microfluidic hardware, and cloud-based bioinformatics. Focused on identifying multi-pathogen threats and antimicrobial resistance, this project is built for high-impact deployment in both clinical and field settings.

Learn More

Synthetic Diagnostics

PathCrisp

Overview

PathCrisp is a next-gen diagnostics platform combining CRISPR-based detection, microfluidic hardware, and cloud-based bioinformatics. Focused on identifying multi-pathogen threats and antimicrobial resistance, this project is built for high-impact deployment in both clinical and field settings.

Learn More

Synthetic Diagnostics

PathCrisp

Overview

PathCrisp is a next-gen diagnostics platform combining CRISPR-based detection, microfluidic hardware, and cloud-based bioinformatics. Focused on identifying multi-pathogen threats and antimicrobial resistance, this project is built for high-impact deployment in both clinical and field settings.

Learn More

MRNA Vaccines

Srishti Therapeutics

Overview

Srishti Therapeutics is developing mRNA vaccines targeting vector-borne diseases using hybrid antigen design. Supported by philanthropic grants, the project is advancing toward IND readiness and exploring new financial mechanisms to scale impact across underserved regions.

Learn More

MRNA Vaccines

Srishti Therapeutics

Overview

Srishti Therapeutics is developing mRNA vaccines targeting vector-borne diseases using hybrid antigen design. Supported by philanthropic grants, the project is advancing toward IND readiness and exploring new financial mechanisms to scale impact across underserved regions.

Learn More

MRNA Vaccines

Srishti Therapeutics

Overview

Srishti Therapeutics is developing mRNA vaccines targeting vector-borne diseases using hybrid antigen design. Supported by philanthropic grants, the project is advancing toward IND readiness and exploring new financial mechanisms to scale impact across underserved regions.

Learn More

Integrated Therapeutics

CureGen

Overview

CureGen fuses gene editing, advanced biofabrication, and AI-powered analytics to accelerate disease understanding and therapeutic development.

Learn More

Integrated Therapeutics

CureGen

Overview

CureGen fuses gene editing, advanced biofabrication, and AI-powered analytics to accelerate disease understanding and therapeutic development.

Learn More

Integrated Therapeutics

CureGen

Overview

CureGen fuses gene editing, advanced biofabrication, and AI-powered analytics to accelerate disease understanding and therapeutic development.

Learn More

Climate Risk Modeling

Climactic

Overview

Climactic provides AI-based predictive models for climate risk mitigation, supporting adaptation, insurance, and resilience solutions.

Learn More

Climate Risk Modeling

Climactic

Overview

Climactic provides AI-based predictive models for climate risk mitigation, supporting adaptation, insurance, and resilience solutions.

Learn More

Climate Risk Modeling

Climactic

Overview

Climactic provides AI-based predictive models for climate risk mitigation, supporting adaptation, insurance, and resilience solutions.

Learn More

Applications

Verticals we are innovating

Verticals we are innovating

Smart Farming

Personalized Medicine

Wearable Health Devices

Personalized Medicine

3D Bio Printing

Personalized Medicine

Genetically Modified Organisms

Personalized Medicine

Bioremediation

Personalized Medicine

Bio Fuels

Personalized Medicine

Personalized Medicine

Bio-Pharmaceuticals

Biopharmaceuticals

Personalized Medicine

Regenerative Medicine

Personalized Medicine

FAQ

Frequently asked questions

Frequently asked questions

Frequently asked questions

What is your tokenization process?
Where do the scientific assets come from?
Who is BioVergence for?
How do I get started?

Modular bioscience, at your fingertips

Modular bioscience, at your fingertips

Modular bioscience, at your fingertips

AI-native capital formation for scientific assets

Address

750 Main Street, Cambridge, MA 02139, USA

Poststrasse 30, 6300 Zug, Switzerland

©2026 BioVergence All Rights Reserved